Will InMed Pharmaceuticals Inc (INM) Trail the Rest of the Stocks in the Healthcare Sector?

InMed Pharmaceuticals Inc (INM) is near the middle in its sector according to InvestorsObserver. INM gets an overall rating of 36. That means it scores higher than 36% of stocks. InMed Pharmaceuticals Inc gets a 38 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

INM has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on INM!

See Full INM Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With InMed Pharmaceuticals Inc Stock Today?

InMed Pharmaceuticals Inc (INM) stock is lower by -9.84% while the S&P 500 is higher by 0.29% as of 11:38 AM on Friday, Oct 27. INM has fallen -$0.07 from the previous closing price of $0.68 on volume of 283,616 shares. Over the past year the S&P 500 has gained 8.98% while INM has fallen -81.00%. INM lost -$3.25 per share the over the last 12 months. Click Here to get the full Stock Report for InMed Pharmaceuticals Inc stock.